"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Descriptor ID |
D005910
|
MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 1 | 9 |
1995 | 7 | 2 | 9 |
1996 | 17 | 3 | 20 |
1997 | 9 | 4 | 13 |
1998 | 16 | 0 | 16 |
1999 | 12 | 6 | 18 |
2000 | 10 | 4 | 14 |
2001 | 14 | 1 | 15 |
2002 | 15 | 4 | 19 |
2003 | 20 | 5 | 25 |
2004 | 18 | 1 | 19 |
2005 | 17 | 5 | 22 |
2006 | 26 | 3 | 29 |
2007 | 35 | 5 | 40 |
2008 | 36 | 4 | 40 |
2009 | 29 | 8 | 37 |
2010 | 47 | 7 | 54 |
2011 | 42 | 4 | 46 |
2012 | 37 | 3 | 40 |
2013 | 29 | 7 | 36 |
2014 | 29 | 3 | 32 |
2015 | 37 | 6 | 43 |
2016 | 35 | 3 | 38 |
2017 | 42 | 6 | 48 |
2018 | 35 | 5 | 40 |
2019 | 38 | 2 | 40 |
2020 | 34 | 4 | 38 |
2021 | 38 | 1 | 39 |
2022 | 55 | 2 | 57 |
2023 | 43 | 0 | 43 |
2024 | 15 | 0 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Understanding the mechanisms of diffuse midline glioma cell migration toward therapeutic targeting. Neuro Oncol. 2024 03 04; 26(3):569-570.
-
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab. J Neurooncol. 2024 Mar; 167(1):181-188.
-
Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas. J Clin Invest. 2024 Feb 15; 134(4).
-
Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. J Natl Cancer Inst. 2024 Feb 08; 116(2):288-298.
-
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice. Mol Ther. 2024 Mar 06; 32(3):722-733.
-
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro Oncol. 2024 02 02; 26(2):236-250.
-
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes. JCO Precis Oncol. 2024 Feb; 8:e2300442.
-
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas. Nat Commun. 2024 Jan 25; 15(1):730.
-
An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation. J Neuropathol Exp Neurol. 2024 Jan 19; 83(2):139-141.
-
The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.